A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice

Vaccine
Aviva JosephE Kedar

Abstract

Although most pathogens use the mucosal routes for invasion, the majority of currently available vaccines are administered parenterally. Injectable vaccines induce good systemic immunity but often unsatisfactory mucosal immunity. A non-injectable mucosal vaccine, which can be self-administered intranasally, may provide both effective systemic and mucosal immunity and can be used for vaccination of large populations within a short period of time in case of a sudden epidemic. Here, we report on a new intranasal (i.n.) influenza vaccine, based on a novel polycationic sphingolipid, N-palmitoyl D-erythro-sphingosyl carbamoyl-spermine (ceramide carbamoyl-spermine = CCS), having combined carrier and adjuvant activities, which elicits, in mice, strong systemic (serum) and local (lung and nasal) humoral and cellular responses, and provides protective immunity. In a comparative study, we show that both unmodified commercial vaccine and vaccine formulated with neutral or anionic liposomes were poorly immunogenic upon i.n. administration. Of five vaccine formulations based on well-established monocationic lipids in the form of unsized liposomes, three (DC-Chol, DDAB, and DSTAP-based) resulted in low serum and local responses, while two oth...Continue Reading

References

Oct 26, 1976·Biochimica Et Biophysica Acta·C Tanford, J A Reynolds
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C WalkerG V Van Nest
Nov 14, 1997·British Journal of Pharmacology·M C Filion, N C Phillips
Dec 17, 1997·Biochemical and Biophysical Research Communications·T NakanishiT Mayumi
Mar 5, 1999·Immunology Letters·A M MowatN Lycke
Oct 20, 1999·Methods : a Companion to Methods in Enzymology·G GregoriadisY Perrie
Nov 24, 1999·Immunological Reviews·C CzerkinskyJ B Sun
Aug 8, 2001·Archives of Biochemistry and Biophysics·Y AramakiS Tsuchiya
Aug 8, 2001·Advanced Drug Delivery Reviews·M A ClarkB H Hirst
Aug 23, 2001·Advanced Drug Delivery Reviews·S S Davis
Aug 23, 2001·Advanced Drug Delivery Reviews·P N Boyaka, J R McGhee
Aug 23, 2001·Advanced Drug Delivery Reviews·L IllumS S Davis
Aug 23, 2001·Advanced Drug Delivery Reviews·I Jabbal-GillL Illum
Aug 23, 2001·Advanced Drug Delivery Reviews·K F HuB Morein
Aug 25, 2001·Rinsho byori. The Japanese journal of clinical pathology·A Oya
Jan 23, 2002·Vaccine·John StambasChristina Cheers
Feb 13, 2002·Drug Discovery Today·Randall J MrsnyDavid J FitzGerald
Jun 28, 2002·International Journal of Pharmaceutics·Crispin R Dass
Aug 17, 2002·Current Opinion in Immunology·Kristina Eriksson, Jan Holmgren
Aug 20, 2002·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Reinhard Glück
Dec 13, 2002·Vaccine·Gregory GregoriadisBrenda McCormack
Jan 16, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shaobing ZhouHeming Li
Jan 18, 2003·Vaccine·Guido DietrichJean-François Viret
Apr 8, 2003·Current Medicinal Chemistry·Céline NicolazziMichel Bessodes
Aug 6, 2003·Expert Review of Vaccines·Derek T O'Hagan, Manmohan Singh
Aug 6, 2003·Expert Review of Vaccines·Dennis M Klinman
Feb 27, 2004·The New England Journal of Medicine·Robert B Couch
Feb 27, 2004·The New England Journal of Medicine·Margot MutschRobert Steffen

❮ Previous
Next ❯

Citations

Nov 29, 2007·Future Microbiology·Volker GerdtsLorne A Babiuk
Dec 18, 2010·Expert Review of Vaccines·George MutwiriAndrew Potter
Apr 22, 2011·Expert Review of Vaccines·Dennis ChristensenElse Marie Agger
May 1, 2008·Expert Review of Vaccines·De-chu C Tang, Kent R Van Kampen
Jul 26, 2012·Expert Review of Vaccines·Karen Smith KorsholmDennis Christensen
Oct 13, 2007·Expert Review of Vaccines·Dennis ChristensenElse Marie Agger
Sep 5, 2006·Expert Opinion on Drug Delivery·Hansi J Dean
May 13, 2010·Expert Opinion on Drug Delivery·Béatrice HeurtaultFrançoise Pons
Aug 9, 2007·Expert Opinion on Drug Delivery·Dmytro S SilinAldar S Bourinbaiar
Jan 4, 2008·Journal of Drug Targeting·Bram SlütterWim Jiskoot
Mar 19, 2011·Expert Opinion on Drug Delivery·Malou Henriksen-LaceyDennis Christensen
Nov 3, 2010·Journal of Drug Targeting·Barbara C Baudner, Derek T O'Hagan
Jul 29, 2008·Journal of Pharmaceutical Sciences·Sameer SharmaYan Chen
Jun 5, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Olga Kammona, Costas Kiparissides
Apr 11, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Christophe Barnier QuerWim Jiskoot
Jan 25, 2011·Journal of Colloid and Interface Science·Yechezkel BarenholzFabrizio Pascale
Jan 6, 2009·Advanced Drug Delivery Reviews·Noemi CsabaMaria Jose Alonso
Apr 22, 2008·Progress in Lipid Research·Caroline LonezJean-Marie Ruysschaert
Feb 5, 2008·Vaccine·Dubravka Grdic EliassonNils Lycke
Mar 2, 2011·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Eder Lilia Romero, Maria Jose Morilla
Aug 8, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Alexis García, Juan B De Sanctis
Jun 17, 2010·Journal of Liposome Research·Julieta GasparriSilvia del Valle Alonso
Jun 12, 2009·Journal of Liposome Research·Dennis ChristensenYvonne Perrie
Nov 19, 2017·Journal of Nanobiotechnology·Luis O De Serrano, David J Burkhart
Sep 24, 2013·Expert Review of Vaccines·Orli Even-OrYechezkel Barenholz
Jul 11, 2020·Biomimetics·Ana Maria Carmona-Ribeiro, Yunys Pérez-Betancourt
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wei JiaYou-Wen He
Apr 25, 2012·Annual Review of Biomedical Engineering·Kim A WoodrowDavid D Lo
Jan 28, 2017·Journal of Immunology Research·Valentina BernasconiNils Y Lycke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.